Pictured: Paul Russo
In the Clinic
By Media Staff  |  Monday, May 20, 2013

A study has found that the majority of kidney cancer patients with small tumors have their entire kidney removed, which can increase the risk of developing chronic kidney disease and cardiovascular complications.

Pictured: Siddhartha Mukherjee
Event
By Celia Gittelson  |  Friday, May 17, 2013

Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.

Pictured: Melanocytes
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 14, 2013

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

Pictured: Christopher Lima
Honor
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, May 9, 2013

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

Pictured: Robert Motzer & Suzanne Gornell
Video
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, May 8, 2013

Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005.

Pictured: Douglas Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, May 1, 2013

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Pictured: Charles Sawyers
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: Liang Deng
Profile
By Jim Stallard, MA, Writer/Editor  |  Friday, April 26, 2013

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Pictured: Gary Schwartz & Mark Dickson
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan Kettering investigators show promising results against different types of sarcoma.

Pictured: Andrew Vickers
Finding
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, April 17, 2013

A study led by Memorial Sloan Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Pictured: Dan Douer
Video
By Memorial Sloan Kettering  |  Wednesday, April 10, 2013

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Pictured: José Baselga
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 8, 2013

Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Pictured: Paul Sabbatini
Q&A
By Media Staff  |  Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan Kettering’s clinical research program.

Pictured: Kenneth Offit
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Center News

Stay Informed

Get the latest information about cancer care and research every month.